Preview
Unable to display preview. Download preview PDF.
References
Apte R, Sinha D, Mayhew E, Wistow G, Niederkorn J (1998) Role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege. J Immunol 160:5693–5696
Altieri DC, Stamnes SJ (1994) Protease-dependent T cell activation: ligation of effector cell protease receptor-1 (EPR-1) stimulates lymphocyte proliferation. Cell Immunol 155:372–383
Bacher M, Meinhardt A, Lan H, Dhabar B, Mu W, Metz C, Chesnety J, Gemsa D, Donnelly T, Atkins R, Bucala R (1998) MIF expression in the rat brain-implications for neuronal function. Mol Med 4:217–230
Bacher M, Metz C, Calandra T, Mayer K, Chesney J, Lohoff M, Gemsa D, Donnelly T, Bucala R (1996) An essential role for MIF in T cell activation. Proc Natl Acad Sci USA 93:7849–7854
Bendrat K, Al-Abed Y, Callaway D, Peng T, Calandra T, Metz C, Bucala R (1997) Biochemical and mutational investigations of the enzymatic activity of macrophage migration inhibitory factor. Biochemistry 36:15356–15362
Bernhagen J, Calandra T, Bucala R (1998) Regulation of the immune response by macrophage migration inhibitory factor: biological and structural features. J Mol Med 76:151–161
Bernhagen J, Bacher M, Calandra T, Metz C, Doty SB, Donnelly T, Bucala R (1996) An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction. J Exp Med 183:277–282
Bernhagen J, Calandra T, Mitchell RA, Martin SB, Tracey KJ, Voelter W, Manogue KR, Cerami A, Bucala R (1993) MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365:756–759
Blocki F, Schlievert P, Wackett L (1992) Rat liver protein linking chemical and immunological detoxification systems. Nature 360:269–270
Bloom BR, Bennett B (1966) Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153:80–82
Bozza M, Satoskar AR, Lin G, Lu B, Humbles AA, Gerard C, David JR (1999) Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J. Exp Med 189:341–346
Bucala R (1996) MIF rediscovered: cytokine, pituitary hormone, and glucocorticoid-induced regulator of the immune response. FASEB J 10:1607–1613
Calandra, T, Speigel, LA, Metz, CH, Bucala, RH (1998) Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria. Proc Natl Acad Sci USA 95:11383–11388
Calandra T, Bernhagen J, Metz CN, Spiegel L, Bacher M, Donnelly T, Cerami A, Bucala R (1995) MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377:68–71
Calandra T, Bernhagen J, Mitchell RA, Bucala R (1994) The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 179:1895–1902
Calandra T, Bucala R (1996) Macrophage migration inhibitory factor: a counter-regulator of glucocorticoid action and critical mediator of septic shock. J Inflamm 47:39–51
Cerretti DP, Kozlosky CJ, Vanden Bos T, Nelson N, Gearing DP, Beckmann MP (1993) Molecular characterization of receptors for human interleukin-8, GRO/melanoma growth-stimulatory activity and neutrophil activating peptide-2. Mol Immunol 30:359–367
Chaput M, Claes V, Portetelle D, Cludts I, Cravador A, Burny A, Gras H, Tartar A (1988) The neurotropic factor neuroleukin is 90% homologous with phosphohexose isomerase. Nature 332:454–455
Chen H, Centola M, Altschul SF, Metzger H (1998) Characterization of gene expression in resting and activated mast cells. J Exp Med 188:1657–1668
Chook YM, Gray JV, Ke H, Lipscomb WN (1994) The monofunctional chorismate mutase from Bacillus subtilis. Structure determination of chorismate mutase and its complexes with a transition state analog and prephenate, and its implications for the mechanism of the enzymatic reaction. J Mol Biol 240:476–500
Churchill, WH, Piessens, WF, Sulis, CA, David, JR (1975) Macrophages activated as suspension cultures with lymphocyte mediators devoid of antigen become cytotoxic for tumor cells. J Immunol 115:781–786
David JR (1966) Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci USA 56:72–77
de Vos AM, Ultsch M, Kossiakoff AA (1992) Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 255:306–312
Deutsch J (1997) Determination of p-hydroxyphenylpyruvate, p-hydroxyphenyl-lactate and tyrosine in normal human plasma by gas chromatography-mass spectrometry isotope-dilution assay. J Chromatogr B 690:1–6
Donnelly SC, Haslett C, Reid PT, Grant IS, Wallace W, Metz CN, Bruce LJ, Bucala R (1997) Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med 3:320–323
George M, Vaughn JH (1962) In vitro cell migration as a model for delayed hypersensitivity. Proc Soc Exp Biol Med 111:514–521
Hajipour G, Johnson WH, Dauben PD, Stolowich NJ, Whitman CP (1993) Chemical and enzymatic ketonization of 5-(carboxymethyl)-2-hydroxymuconate. J Amer Chem Soc 115:3533–3542
Herriott MJ, Jiang H, Stewart CA, Fast DJ, Leu RW (1993) Mechanistic differences between migration inhibitory factor (MIF) and IFN-γ for macrophage activation. J Immunol 150:4524–4531
Hoogewerf AJ, Leone JW, Reardon IM, Howe WJ, Asa D, Heinrikson RL, Ledbetter SR (1996) CXC chemokines connective tissue activating peptide-III and neutrophil activating peptide-2 are heparin/heparan sulfate-degrading enzymes. J Biol Chem 270:3268–3277
Ishizaka K, Nakano T, Ishii Y, Liu YC, Mikayama T, Mori A (1996) Controversial issues and possible answers on the antigen-specific regulation of the IgE antibody response. Adv Exp Med Biol 409:317–325
Juttner S, Bernhagen J, Metz CN, Rollinghoff M, Bucala R, Gessner A (1998) Migration inhibitory factor induces killing of Leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF-alpha. J Immunol 161:2383–2390
Kappler J, Kotzin B, Herron L, Gelfand EW, Bigler RD, Boylston A, Carrel S, Posnett DN, Choi Y, Marrack P (1989) V beta-specific stimulation of human T cells by staphylococcal toxins. Science 244:811–813
Kato, Y, Muto T, Tomura T, Tsumura H, Watarai H, Mikayama T, Ishizaka K, Kuroki R (1996) The crystal structure of human glycosylation-inhibiting factor is a trimeric barrel with three 6-stranded beta-sheets. Proc Natl Acad Sci USA 93:3007–3010
Kleeman R, Kapurniotu A, Frank RW, Gessner A, Mischke R, Flieger O, Juttner S, Brunner H, Bernhagen J (1998) Disulfide analysis reveals a role for macrophage migration inhibitory factor (MIF) as thiol-protein oxidoreductase. J Mol Biol 280:85–102
Knox W, Pitt B (1957) Enzymatic catalysis of the keto-enol tautomerization of phenylpyruvic acids. J Biol Chem 225:675–688
Kobayashi S, Yoshida K, Ohshima T, Esumi N, Paralkar VM, Wistow GJ, Kulkarni AB (1998) DNA sequence motifs are associated with aberrant homologous recombination in the mouse macrophage migration inhibitory factor (Mif) locus. Gene 215:85–92
Lan HY, Mu W, Yang N, Meinhardt A, Nikolic-Paterson DJ, Ng YY, Bacher M, Atkins RC, Bucala R (1996) De Novo renal expression of macrophage migration inhibitory factor during the development of rat crescentic glomerulonephritis. Am J Pathol 149:1119–1127
Lan HY, Nikolic-Paterson DJ, Mu W, Vannice JL, Atkins RC (1995) Interleukin-1 receptor antagonist halts the progression of established crescentic glomerulonephritis in the rat. Kidney Int 47:1303–1309
Lan HY, Nikolic-Paterson DJ, Zarama M, Vannice JL, Atkins RC (1993) Suppression of experimental crescentic glomerulonephritis by the interleukin-1 receptor antagonist. Kidney Int 43:479–485
Lan H, Bacher M, Yang N, Mu W, Nikolic-Paterson D, Metz C, Meinhardt A, Bucala R, Atkins R (1997) The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat. J Exp Med 185:1455–1466
Leech M, Metz C, Santos L, Peng T, Holdsworth S, Bucala R, Morand E (1998) Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis. Arthritis Rheum 41:910–917
Leiva MC, Lyttle CR (1992) Leukocyte chemotactic activity of FKBP and inhibition of FK506. Biochem Biophys Res Comm 186:1178–1183
Liu Y-C, Nakano, T, Elly, C, Ishizaka, K (1994) Requirement of posttranslational modifications for the generation of biologic activity of glycosylation-inhibiting factor. Proc Natl Acad Sci USA, 91:11227–11231
Makita, H, Nishimura, M, Miyamoto, K, Nakano, T, Tanino, Y, Hirokawa, J, Nishihara, J, Kawakami, Y (1998) Effect of anti-macrophage migration inhibitory factor antibody on lipopolysaccharide-induced pulmonary neutrophil accumulation. Am J Respir Crit Care Med 158:573–579
Marrack P, Kappler J 1990 The staphylococcal enterotoxins and their relatives. Science 248:705–711
Matsuda A, Kotake S, Tagawa Y, Matsuda H, Nishihira J (1996) Detection and immunolocalization of macrophage migration inhibitory factor in rat iris and ciliary epithelium. Immunol Lett 53:1–5
Matsunaga J, Sinha D, Pannell L, Santis C, Solano F, Wistow GJ, Hearing VJ (1999) Enzyme activity of macrophage migration inhibitory factor toward oxidized catecholamines. J. Biol. Chem. 274:3268–3271
McNamara MJ, Norton JA, Nauta RJ, Alexander HR (1993) Interleukin-1 receptor antibody protection and treatment against lethal endotoxemia in mice. J Surg Res 54:316–321
Meinhardt A, Bacher M, McFarlane JR, Metz CN, Seitz J, Hedger MP, DeKretser DM, Bucala R (1996) MIF production by Leydig cells: evidence for a role in the regulation of testicular function. Endocrinology 137:5090–5095
Metz C, Bucala R (1997) Role of macrophage migration inhibitory factor in the regulation of the immune response. Adv Immunol 66:197–223
Mikayama T, Nakano T, Gomi H, Nakagawa Y, Liu YC, Sato M, Iwamatsu A, Ishii Y, Weiser WY, Ishizaka K (1993) Molecular cloning and functional expression of a cDNA encoding glycosylation-inhibiting factor. Proc Natl Acad Sci USA 90:10056–10060
Mikulowska A, Metz C, Bucala R, Holmdahl R (1997) Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice. J Immunol 158:5514–5517
Moroianu J, Riordan JF (1994a) Nuclear translocation of angiogenin in proliferating endothelial cells is essential to its angiogenic activity. Proc Natl Acad Sci USA 1994 91:1677–16781
Moroianu J, Riordan JF (1994b) Identification of the nucleolar targeting signal of human angiogenin. Biochem Biophys Res Commun 203:1765–72
Muhlhahn P, Bernhagen J, Czisch M, Georgescu J, Renner C, Ross A, Bucala R, Holak TA (1996) NMR characterization of structure, backbone dynamics, and glutathione binding of the human macrophage migration inhibitory factor (MIF). Prot Sci 5:2095–2103
Murzin, AG (1996) Structural classification of proteins: new superfamilies. Curr Opin Str Biol 6:386–394
Nathan, CF, Karnovsky, ML, David, JR (1971) Alterations of macrophage functions by mediators from lymphocytes. J Exp Med 133:1356–1376
Nathan, CF, Remold, HG, David, JR (1973) Characterization of a lymphocyte factor which alters macrophage function. J Exp Med 137:275–288
Nishibori M, Nakaya N, Mori S, Saeki K (1997) Immunohistochemical localization of macrophage migration inhibitory factor (MIF) in tanycytes, subcommissural organ and choroid plexus in the rat brain. Brain Res 758:259–262
Nishibori M, Nakaya N, Tahara A, Kawabata M, Mori S, Saeki K (1996) Presence of macrophage migration inhibitory factor (MIF) in ependyma, astrocytes and neurons in the bovine brain. Neurosci Lett 213:193–196
Nishino T, Bernhagen J, Shliki H, Calandra T, Dohl K, Bucala R (1995) Localization of macrophage migration inhibitory factor (MIF) to secretory granules within the corticotrophic and thyrotrophic cells of the pituitary gland. Mol Med 1:781–788
Okusawa S, Gelfand JA, Ikejima T, Connolly RJ, Dinarello CA (1988) Interleukin-1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J Clin Inv 81:1162–1172
Onodera S, Suzuki K, Matsuno T, Kaneda K, Takagi M, Nishihira J (1997) Macrophage migration inhibitory factor induces phagocytosis of foreign particles by macrophages in autocrine and paracrine fashion. Immunology 92:131–137
Piatigorsky J, Graeme WJ (1989) Enzyme/Crystallins: Gene sharing as an evolutionary strategy. Cell 57:197–199
Puig A, Lyles MM, Noiva R, Gilbert HF (1994) The role of the thiol/disulfide centers and peptide binding site in the chaperone and anti-chaperone activities of protein disulfide isomerase. J Biol Chem 269:9128–9135
Rosengren E, Aman P, Thelin S, Hansson C, Ahlfors S, Bjork P, Jacobsson L, Rorsman H (1997) The macrophage migration inhibitory factor MIF is a phenylpyruvate tautomerase. FEBS Lett 417:85–88
Rosengren E, Bucala R, Arnan P, Jacobsson L, Odh G, Metz CN, Rorsman H (1996) The immunoregulatory macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reaction. Mol Med 2:143–149
Rossi AG, Haslett C, Hirani N, Greening AP, Rahman I, Metz CN, Bucala R, Donnelly SC (1998) Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF). Potential role in asthma. J Clin Invest 101:2869–2874
Shapiro R, Fox EA, Riordan JF (1989) Role of lysines in human angiogenin: chemical modification and site-directed mutagenesis. Biochemistry 28:1726–1732
Sherry B, Yarlett N, Strupp A, Cerami A (1992) Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide-activated macrophages. Proc Natl Acad Sci USA 89:3511–3515
Stamps SL, Fitzgerald MC, Whitman CP (1998) Characterization of the role of the amino-terminal proline in the enzymatic activity catalyzed by macrophage migration inhibitory factor. Biochemistry 37:10195–10202
Stivers JT, Abeygunawardana C, Mildvan AS, Hajipour G, Whitman, CP (1996) 4-oxalocrotonate tautomerase: pH dependence of catalysis and pKa values of active site residues. Biochemistry 35:814–823
Subramanya HS, Roper DI, Dauter D, Dodson EJ, Davies GJ, Wilson KS, Wigley DB (1996) Enzymatic ketonization of 2-hydroxymuconate: specificity and mechanism investigated by the crystal structures of two isomerases. Biochemistry 35:792–802
Sugie, K Nakano, T, Tomura, T, Takakura, K, Mikayama, T, Ishizaka, K (1997) High affinity binding of bioactive glycosylation-inhibiting factor to antigen-primed T cells and natural killer cells. Proc Natl Acad Sci USA, 94:5278–5283
Sun HW, Bernhagen J, Bucala R, Lolis E (1996a) Crystal structure at 2.6 Angstrom resolution of human macrophage migration inhibitory factor. Proc Natl Acad Sci USA 93:5191–5196
Sun HW, Swope M, Cinquina C, Bedarkar S, Bernhagen J, Bucala R, Lolis E (1996b) The subunit structure of human macrophage migration inhibitory factor: evidence for a trimer. Protein Eng 1996 9:631–635
Suzuki H, Kanagawa H, Nishihira J (1996a) Evidence for the presence of macrophage migration inhibitory factor in murine reproductive organs and early embryos. Immunol Letters 51:141–147
Suzuki M, Sugimoto H, Nakagawa A, Tanaka I, Nishihira J, Sakai M (1996b) Crystal structure of the macrophage migration inhibitory factor from rat liver. Nat Struct Biol 3:259–266
Swope M, Sun H-W, Blake P, Lolis E (1998a) Direct link between cytokine activity and a catalytic site for macrophage migration inhibitory factor. EMBO J 17:3534–3541
Swope M, Sun H-W, Klockow B, Blake P, Lolis E (1998b) Macrophage migration inhibitory factor interactions with glutathione and S-hexylglutathione. J Biol Chem 273:14877–14884
Takahashi N, Creighton TE (1996) On the reactivity and ionization of the active site cysteine residues of Escherichia coli thioredoxin. Biochemistry 35:8342–8353
Tracey KJ, Beutler B, Lowry SF, Merryweather S, Wolpe S, Milsark IW, Harir RJ, Fahey TJ, Zentella A, Albert JD, Shires GT, Cerami A (1986) Shock and tissue injury induced by recombinant human cachectin. Science 234:470–474
Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, Lowry SF, Cerami A (1987) Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330:662–664
Vu T, Wheaton V, Hung D, Charo I, Coughlin S (1991) Domains specifying thrombin-receptor interaction. Nature 353:674–677
Wada S, Fujimoto S, Mizue Y, Nishihira J (1997) Macrophage migration inhibitory factor in the human ovary: presence in the follicular fluids and production by granulosa cells. Biochem Mol Biol Int 41:805–814
Waeber G, Roduit R, Haefliger J-A, Bonny C, Thompson N, Thorens B, Temler E, Meinhardt A, Bacher M, Metz C, Nicod P, Bucala R (1997) Insulin secretion is regulated by the glucose-dependent production of islet β cell macrophage migration inhibitory factor. Proc Natl Acad Sci USA 94:4782–4787
Watanabe H, Takehana K, Date M, Shinozaki T, Raz A (1996) Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide. Cancer Res 56:2960–3
Weigent, DA (1996) Immunoregulatory properties of growth hormone and prolactin. Pharmacol Ther 69:237–257
Weiser W, Temple P, Witek-Gianotti J, Remold H, Clark S, David J (1989) Molecular cloning of a cDNA encoding a human migration inhibitory factor. Proc Natl Acad Sci USA 86:7522–7526
Wistow G, Shaughness M, Lee D, Hodin J, Zelenka P (1993) A macrophage migration inhibitory factor is expressed in the differentiating cells of the eye lens. Proc Natl Acad Sci USA 90:1272–1275
Xu D, Mcsorley S, Tetley L, Chatfield S, Dougan G, Chan W, Satoskar A, David J, Liew F (1998) Protective effect on Leishmania major infection of migration inhibitory factor, TNF-alpha, and IFN-gamma administered orally via attenuated salmonella typhimurium. J Immunol 160:1285–1289
Xu Q, Leiva MC, Fischkoff SA, Handschumacher RE, Lyttle CR (1992) Leukocyte chemotactic activity of cyclophilin. J Biol Chem 267:11968–11971
Zhang M, Aman P, Grubb A, Panagiopoulos I, Hindemith A, Rosengren E, Rorsman H (1995) Cloning and sequencing of a cDNA encoding rat D-dopachrome tautomerase. FEBS Letts 373:203–206
Zapun A, Cooper L, Creighton TE (1994) Replacement of the active-site cysteine residues of DsbA, a protein required for disulfide bond formation in vivo. Biochemistry 33:1907–1914
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag
About this chapter
Cite this chapter
Swope, M.D., Lolis, E. (1999). Macrophage migration inhibitory factor: Cytokine, hormone, or enzyme?. In: Reviews of Physiology, Biochemistry and Pharmacology, Volume 139. Reviews of Physiology, Biochemistry and Pharmacology, vol 139. Springer, Berlin, Heidelberg. https://doi.org/10.1007/BFb0033647
Download citation
DOI: https://doi.org/10.1007/BFb0033647
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-65694-4
Online ISBN: 978-3-540-49111-8
eBook Packages: Springer Book Archive